CN117769652A - 使用了可溶型clec2的出血性脑卒中的风险评价方法 - Google Patents

使用了可溶型clec2的出血性脑卒中的风险评价方法 Download PDF

Info

Publication number
CN117769652A
CN117769652A CN202280038986.4A CN202280038986A CN117769652A CN 117769652 A CN117769652 A CN 117769652A CN 202280038986 A CN202280038986 A CN 202280038986A CN 117769652 A CN117769652 A CN 117769652A
Authority
CN
China
Prior art keywords
concentration
hemorrhagic stroke
soluble
sclec2
clec2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280038986.4A
Other languages
English (en)
Chinese (zh)
Inventor
和田英夫
川村雅英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN117769652A publication Critical patent/CN117769652A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202280038986.4A 2021-05-31 2022-05-31 使用了可溶型clec2的出血性脑卒中的风险评价方法 Pending CN117769652A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-091607 2021-05-31
JP2021091607 2021-05-31
PCT/JP2022/022077 WO2022255349A1 (ja) 2021-05-31 2022-05-31 可溶型ｃｌｅｃ２を用いた出血性脳卒中のリスク評価法

Publications (1)

Publication Number Publication Date
CN117769652A true CN117769652A (zh) 2024-03-26

Family

ID=84323410

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280038986.4A Pending CN117769652A (zh) 2021-05-31 2022-05-31 使用了可溶型clec2的出血性脑卒中的风险评价方法

Country Status (6)

Country Link
US (1) US20240264175A1 (https=)
EP (1) EP4350350A4 (https=)
JP (1) JPWO2022255349A1 (https=)
KR (1) KR20240017001A (https=)
CN (1) CN117769652A (https=)
WO (1) WO2022255349A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025075139A1 (ja) * 2023-10-06 2025-04-10 Ｐｈｃ株式会社 可溶型ｃｌｅｃ－２を用いた脳心血管・腎イベントの長期的発症ハイリスク評価法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6078845U (ja) 1983-11-04 1985-06-01 ライオン株式会社 食用廃油固化処理用具
AU2002359815A1 (en) * 2001-12-19 2003-07-09 Immunex Corporation C-type lectin polypeptide, polynucleotide and methods of making and use thereof
JP6078845B2 (ja) * 2012-09-28 2017-02-15 株式会社Ｌｓｉメディエンス 可溶型ｃｌｅｃ−２に基づく血小板活性化測定方法
US10227407B2 (en) * 2013-10-10 2019-03-12 Yukinari Kato Anti-podoplanin antibody
JP7172286B2 (ja) 2018-08-28 2022-11-16 スズキ株式会社 ニーエアバッグ取付け構造
JP6883348B2 (ja) 2019-06-26 2021-06-09 稔 甲斐 閉塞防止機能付振動篩用網及び振動篩装置
EP4113524A4 (en) * 2020-02-28 2024-03-06 LSI Medience Corporation METHOD FOR MEASURING PLATELE ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELE COUNT

Also Published As

Publication number Publication date
KR20240017001A (ko) 2024-02-06
JPWO2022255349A1 (https=) 2022-12-08
WO2022255349A1 (ja) 2022-12-08
EP4350350A1 (en) 2024-04-10
US20240264175A1 (en) 2024-08-08
EP4350350A4 (en) 2025-04-30

Similar Documents

Publication Publication Date Title
Yildirim et al. Preoperative neutrophil-to-lymphocyte ratio has a better predictive capacity in diagnosing tubo-ovarian abscess
Cai et al. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage
CN115190973B (zh) 基于可溶性clec-2与血小板数的血小板活化测定方法
JPWO2007094394A1 (ja) 意識障害患者における病態の検出方法及び検出用キット
CN117769652A (zh) 使用了可溶型clec2的出血性脑卒中的风险评价方法
EP4350349A1 (en) Method for evaluating risk of acute cerebral vascular disease using soluble clec2
Muharam et al. Correlation of calprotectin serum levels with degrees of endometriosis: A cross-sectional study
JP7851566B2 (ja) 早発性子癇前症の予後についてのバイオマーカー
KR102906320B1 (ko) 기분장애형 정신질환과 조현병 구분용 바이오마커 및 이의 용도
HK40106384A (en) Method for assessing risk of hemorrhagic stroke using soluble clec2
JPWO2012067151A1 (ja) ＣａｒｔｉｌａｇｅＡｃｉｄｉｃＰｒｏｔｅｉｎ１蛋白質による脳梗塞の検査方法
HK40127498A (en) Method for evaluating risk of acute cerebral vascular disease using soluble clec2
HK40105374A (en) Method for evaluating risk of acute cerebral vascular disease using soluble clec2
RU2833111C1 (ru) Способ прогноза хронической плацентарной недостаточности после перенесённой новой коронавирусной инфекции (НКВИ) лёгкой и среднетяжёлой формы
JP7808059B2 (ja) 可溶型ｃｌｅｃ２を用いた癌患者における血栓症リスクの予測方法
Eldahdoh et al. Mean Platelet Volume versus Alvarado Score as Predictor of Acute Appendicitis
RU2543653C1 (ru) Способ диагностики нарушений свертываемости крови у беременных во 2-3 триместре
RU2602914C1 (ru) Способ оценки степени тяжести воспалительных заболеваний органов малого таза
Ali et al. Anjumun Ara, Muhammed Zafar Iqbal,(2025). Association of Mean Platelet Volume with the Risk of Preterm Premature Rupture of Membranes
JP2026501110A (ja) 早発性子癇前症の予後についての多重ｓｆｌｔ－１測定
HK40129389A (zh) 用於早发型先兆子痫预後的多个sflt-1测量值
Hsiao et al. D-dimer assay not adequate for spontaneous intracranial hemorrhage screening
JP2024027767A (ja) 可溶型ｃｌｅｃ２を用いた血小板減少性疾患の診断法
KOCYIGIT et al. Raftlin, presepsin levels and thiol-disulphide homeostasis in acute appendicitis: A pilot study.
JPWO2012067152A1 (ja) ＥｎｄｏｔｈｅｌｉａｌＰｒｏｔｅｉｎＣＲｅｃｅｐｔｏｒ蛋白質による脳梗塞の検査方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination